IgE — Drug Target

All drugs that target IgE — marketed and clinical-stage. Includes 1 drug classes acting on this target.

Drug classes

Monoclonal antibody

Phase 3 pipeline (2)

• Omalizumab for injection · CSPC Baike (Shandong) Biopharmaceutical Co., Ltd. · Monoclonal antibody · Immunology
  Omalizumab is a monoclonal antibody that targets the IgE molecule, preventing it from binding to its receptor on mast cells and basophils.
• Placebo to omalizumab · Novartis · Monoclonal antibody · Immunology
  Omalizumab is a recombinant DNA-derived humanized IgG1 monoclonal antibody that selectively binds to human immunoglobulin E (IgE) with high affinity.